Short answer
SHOULDER INNOVATIONS, INC. (SI) filed its Q1 2026 10-Q quarterly report on May 13, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $17M with net income of −$8M.
Q1 2026 key financials · XBRL
- Revenue
- $17M
- Net income
- −$8M
- Operating margin
- -53.7%
- Gross margin
- 77.7%
- EPS (diluted)
- −$0.41
Source: XBRL data from the SHOULDER INNOVATIONS, INC. (SI) Q1 2026 10-Q on SEC EDGAR. USD.
SHOULDER INNOVATIONS, INC. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $16.708M, up 64.9% YoY from $10.132M
- Gross margin 77.7% vs 76.9% YoY
- Implant systems sold 2,184 vs 1,443 YoY
- Net loss $8.379M vs $4.662M; operating loss $8.976M vs $4.294M
- Cash, equivalents and marketable securities $108.538M; continued expected operating losses and cash spending for scaling and R&D
Risk Factors
- No material changes to risk factors from the 2025 Annual Report
- IPO proceeds $64,212 thousand invested primarily in savings and money market accounts
- Common-stock dilution risk from COO trading plan covering up to 67,500 shares through February 15, 2027
- Market-price risk: adverse events could cause common-stock value decline or total investment loss
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SHOULDER INNOVATIONS, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.